Activated Ras signaling pathways and reovirus oncolysis: an update on the mechanism of preferential reovirus replication in cancer cells [PDF]
The development of wild-type, unmodified Type 3 Dearing (T3D) strain reovirus as an anticancer agent has currently expanded to 32 clinical trials (both completed and ongoing) involving reovirus in the treatment of cancer.
Jun eGong, Monica Mirela Mita
doaj +4 more sources
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy [PDF]
Background Many solid tumors do not respond to immunotherapy due to their immunologically cold tumor microenvironment (TME). We and others found that oncolytic viruses (OVs), including reovirus type 3 Dearing, can enhance the efficacy of immunotherapy by
Rob C Hoeben +11 more
doaj +2 more sources
Activation of p53 by chemotherapeutic agents enhances reovirus oncolysis. [PDF]
Mammalian reovirus is a benign virus that possesses the natural ability to preferentially infect and kill cancer cells (reovirus oncolysis). Reovirus exploits aberrant Ras signalling in many human cancers to promote its own replication and spread.
Da Pan +6 more
doaj +2 more sources
Oncolytic reovirus in canine mast cell tumor. [PDF]
The usage of reovirus has reached phase II and III clinical trials in human cancers. However, this is the first study to report the oncolytic effects of reovirus in veterinary oncology, focusing on canine mast cell tumor (MCT), the most common cutaneous ...
Chung Chew Hwang +11 more
doaj +2 more sources
Reovirus resistance in tumors mediated by elevated ISG expression: overcoming therapeutic resistance via JAK/STAT pathway modulation [PDF]
Background Oncolytic viruses such as reovirus hold significant promise for cancer therapy, but their efficacy varies across tumor types due to heterogeneous tumor cell sensitivity to reovirus.
Yuxin Yang +8 more
doaj +2 more sources
Ataxin-2-like promotes translation of nonpolyadenylated reovirus mRNA [PDF]
Mammalian orthoreovirus (reovirus) nonstructural protein μNS nucleates viral factories (VFs), which are sites of viral genome replication, protein synthesis, and particle assembly.
Xayathed Somoulay +10 more
doaj +2 more sources
Oncolytic reovirus: tumor-microenvironment remodeling, engineering constraints, and translational strategies [PDF]
Oncolytic reovirus (ReoV) has emerged as a promising cancer immunotherapy platform because of its natural tumor tropism and immunostimulatory properties.
Rui Li +11 more
doaj +2 more sources
Reovirus: Friend and Foe [PDF]
Mammalian orthoreovirus (reovirus) is a powerful tool for studying viral replication and pathogenesis. Most reovirus infections are subclinical, however recent work has catapulted reovirus into the clinical spotlight.Owing to its capacity to kill cancer cells more efficiently than normal cells, reovirus is under development as a therapeutic for a ...
Karl W. Boehme
exaly +3 more sources
Paired immunoglobulin-like receptor B is an entry receptor for mammalian orthoreovirus
Mammalian orthoreovirus (reovirus) infects most mammals and is associated with celiac disease in humans. In mice, reovirus infects the intestine and disseminates systemically to cause serotype-specific patterns of disease in the brain.
Pengcheng Shang +14 more
doaj +1 more source
In recent years, reoviruses have been of major interest in immunotherapy because of their oncolytic properties. Preclinical and clinical trials, in which reovirus was used for the treatment of melanoma and glioblastoma, have paved the way for future ...
Raghad Khaleafi +6 more
doaj +1 more source

